EX-10.2
ARDELYX, INC.
CERTAIN IDENTIFIED INFORMATION, MARKED BY [***], HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE COMPANY TREATS AS PRIVATE OR CONFIDENTIAL.
Exhibit 10.2
SECOND AMENDMENT TO MANUFACTURING SERVICES AGREEMENT
This AMENDMENT #2 TO THE MANUFACTURING SERVICES AGREEMENT(the “Second Amendment”) effective as of May 15, 2026 (“Amendment Effective Date”), is by and between Ardelyx Inc., a Delaware corporation with its principal place of business at 400 Fifth Avenue, Suite 210, Waltham, MA 02451 (“Client”), and Patheon Pharmaceuticals Inc., a Delaware corporation with its principal place of business at 2110 East Galbraith Road, Cincinnati, OH 45237 (“Patheon”). Client and Patheon may be referred to herein individually as a “Party” and collectively as the “Parties.”
WHEREAS, Patheon and Client entered into that certain Manufacturing Services Agreement dated May 18, 2020, as amended February 27, 2023 (the “Agreement”); and
…